Skip to content
WideDrive

Zimbabwe Declines ‘Lopsided’ American Health Aid Package Because of Data Apprehensions

Health aid illustration
The proposed US financial assistance was aimed at programmes for treating and preventing HIV/Aids, tuberculosis, and malarial diseases.

The nation of Zimbabwe has turned down a significant US healthcare agreement worth 367 million US dollars (£272m) over five years because of Washington's demand for confidential biological samples.

This move was revealed after a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the deal was "lopsided".

A government spokesperson has since clarified that the US was seeking health data for scientific study and profit while refused to guarantee the resulting advantages from future medical innovations.

"We are forced to start the difficult and regrettable task of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy said the US had donated over $1.9bn as health assistance to Zimbabwe over the last two decades.

A medical body in Zimbabwe has called for more negotiations to find a deal acceptable to both sides so the country's vital HIV treatment initiative can proceed.

Broader Implications

This rejection follows a comparable case in neighbouring Kenya, where a high court suspended a similar deal with the US following concerns were filed about the security of Kenyans' medical information.

After resuming the presidency last year, US President Donald Trump has slashed overseas assistance and shut down the key foreign aid agency.

USAID had overseen aid for the American government, but Trump claimed its expenditure was "wasteful" and his government was seeking government-to-government deals to enhance openness and responsibility.

Based on statements, 16 African countries have to date agreed to similar health pacts, constituting more than $18.3bn in new funding.

Specifics of the Declined Agreement

This assistance for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".

"We believe this partnership might have yielded immense benefits for the people of Zimbabwe, especially the 1.2 million men, women and children currently receiving HIV treatment through American-funded initiatives," the Ambassador added.

However, government spokesperson Nick Mangwana maintained the proposed deal was "unfair".

"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no equivalent guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.

"Effectively, our nation would provide the basic resources for scientific discovery without any assurance that the final treatments would be available to our people should a future disease outbreak arise."

Sovereignty and International Frameworks

Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were undermining systems previously established through the international organization.

Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.

"This mechanism is intended to guarantee that when a country contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the resources to create them."

These objections regarding the US deal "must not be interpreted as anti-American sentiment," Mangwana stressed.

"We are open to further dialogue with our American counterparts on how subsequent collaboration could be designed in a manner that honours the sovereignty and dignity of both nations."

Medical Community Response

The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but urged that talks need to persist given that a large portion of the nation's Aids initiatives relied on foreign aid.

"Where technical issues exist, including those involving information security or implementation frameworks, these can often be addressed through detailed discussion and mutually agreed protections," it added.

This impasse emphasises the complex challenges between receiving vital foreign assistance and protecting a country's data in an increasingly interconnected world.

By

Kathleen Wright

Automotive journalist with over a decade of experience covering car technology and industry innovations.

WideDrive

Type to search articles.